Home

Highly trained and dedicated employees, a favourable patent environment and state-of-the-art manufacturing facilities make Malta a key contributor to the Actavis group of companies. The Maltese operation has benefited from considerable investment from its parent company, which has significantly increased its production capacity for EU markets.

News

02 OCT 2009 / Actavis News Actavis' clients launch first generic Atorvastatin in Spain
14 JUL 2009 / Product News Actavis launches Lendrate tablets

News Archive

Commitment

Social responsibilityCharities & Sponsorships Local communities
Current job vacancies

Featured Products

Lendrate- Alendronic Acid

Alendronic acid is a bisphosphonate, which is used for the treatment of bone diseases.

It inhibits osteoclastic bone resorption with no direct effect on bone formation. Preclinical studies have shown preferential localization of alendronate to sites of active resorption. Activity of osteoclasts is inhibited, but recruitment or attachment of osteoclasts is not affected. The bone formed during treatment with alendronate is of normal quality.

We not only save lives, we save money too